MRK · Merck & Co., Inc.

S&P 500 #37 · NYSE

Risiko 3/10 · Pharma recovery play · $131.82 ▲ 0.81%

Kennzahlen

• Price $131.82
• Market cap $325.6B
• P/E (ttm) 37.24
• Div yield 2.60%
• 52-wk range $76.66 – $135.05
• Index rank #37 / —

Wichtigste Risiken

• Keytruda patent cliff (2028+) (Long-term investors) — HIGH
• Drug pricing regulation / IRA impact (Revenue outlook) — MED
• Pipeline clinical trial failure (Shareholders) — MED
• Generic competition in older drugs (Margins) — LOW

Fazit

Pharma giant surging +55% over 12 months on FDA approvals and oncology pipeline; Keytruda patent cliff in 2028 remains the central long-term risk.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.